Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease

Background: Parkinson's disease (PD) is the second most common neurodegenerative disease, and α-synuclein plays a critical role in the pathogenesis of PD. Studies have revealed controversial results regarding the correlation between motor severity and α-synuclein levels in peripheral blood from...

Full description

Bibliographic Details
Main Authors: Chun-Wei Chang, Shieh-Yueh Yang, Che-Chuan Yang, Chia-Wen Chang, Yih-Ru Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Neurology
Subjects:
Parkinson disease
α-synuclein
biomarker
modified Hoehn and Yahr scale
immunomagnetic reduction
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.01388/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2019.01388/full

Similar Items